pindolol has been researched along with Arterial Occlusive Diseases in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonkodi, S | 1 |
| Kunsági, K | 1 |
| Biliczki, F | 1 |
| Nárai, G | 1 |
| Kelemen, J | 1 |
1 other study available for pindolol and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Combined occurrence of renovascular hypertension, coarctation of the abdominal aorta, occlusion of the celiac and mesenteric arteries and kyphoscoliosis with neurofibromatosis--a case report].
Topics: Adolescent; Aortic Coarctation; Arterial Occlusive Diseases; Celiac Artery; Clopamide; Female; Human | 1984 |